ID

37912

Beskrivning

The Growth Factor Signature (GFS) as an Intermediate Biomarker of Response for Development of PI3K-Pathway Inhibitors in Patients With Breast Cancer (MK-8669-050); ODM derived from: https://clinicaltrials.gov/show/NCT01220570

Länk

https://clinicaltrials.gov/show/NCT01220570

Nyckelord

Versioner (1)
  1. 2019-08-30 2019-08-30 -
Rättsinnehavare

See clinicaltrials.gov

Uppladdad den

30 augusti 2019

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Breast Cancer NCT01220570

Engelsk

Eligibility Breast Cancer NCT01220570

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
participant has operable stage i-iiia invasive breast cancer of the following subtype: er-positive, her2-negative tumor with histologic grade 2 or 3 and ki67 ≥ 15%
Beskrivning

Invasive carcinoma of breast Operable TNM Breast tumor staging | Tumor Estrogen receptor positive | Tumor HER2 Negative | Tumor Histologic Grade | Tumor Ki67 Measurement

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0853879
UMLS CUI [1,2]
C0205188
UMLS CUI [1,3]
C0474926
UMLS CUI [2,1]
C0027651
UMLS CUI [2,2]
C0279754
UMLS CUI [3,1]
C0027651
UMLS CUI [3,2]
C2348908
UMLS CUI [4,1]
C0027651
UMLS CUI [4,2]
C0919553
UMLS CUI [5,1]
C0027651
UMLS CUI [5,2]
C4049944
tumor is at least 2 cm in diameter as assessed by physical or radiographic exam
Beskrivning

Tumor Diameter Physical Examination | Tumor Diameter Diagnostic radiologic examination

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0027651
UMLS CUI [1,2]
C1301886
UMLS CUI [1,3]
C0031809
UMLS CUI [2,1]
C0027651
UMLS CUI [2,2]
C1301886
UMLS CUI [2,3]
C0043299
participant consents to provide an existing tissue sample or to have a core needle biopsy before drug administration
Beskrivning

Availability of Tissue specimen | Core needle biopsy | Status pre- Administration of medication

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0470187
UMLS CUI [1,2]
C1292533
UMLS CUI [2]
C1318309
UMLS CUI [3,1]
C0332152
UMLS CUI [3,2]
C3469597
participant consents to provide tissue samples following drug administration by a second core needle biopsy or from a surgical specimen
Beskrivning

Availability of Tissue specimen | Status post Administration of medication | Core needle biopsy second | Surgical specimen

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0470187
UMLS CUI [1,2]
C1292533
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C3469597
UMLS CUI [3,1]
C1318309
UMLS CUI [3,2]
C0205436
UMLS CUI [4]
C1647891
participant must have adequate organ function
Beskrivning

Organ function

Datatyp

boolean

Alias
UMLS CUI [1]
C0678852
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
participant has received any prior chemotherapy, biological therapy or radiotherapy for breast cancer
Beskrivning

Prior Chemotherapy Breast Carcinoma | Biological treatment Breast Carcinoma | Prior radiation therapy Breast Carcinoma

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0678222
UMLS CUI [2,1]
C1531518
UMLS CUI [2,2]
C0678222
UMLS CUI [3,1]
C0279134
UMLS CUI [3,2]
C0678222
participant has a known hypersensitivity to the components of study drugs or their analogs, including hypersensitivity to macrolide antibiotics (e.g. clarithromycin, erythromycin, azithromycin).
Beskrivning

Hypersensitivity Investigational New Drugs Component | Hypersensitivity Investigational New Drugs Analogs | Allergy to macrolide antibiotic | Clarithromycin allergy | Allergy to erythromycin | Azithromycin allergy

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [1,3]
C1705248
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0013230
UMLS CUI [2,3]
C0243071
UMLS CUI [3]
C0571383
UMLS CUI [4]
C0571384
UMLS CUI [5]
C0014808
UMLS CUI [6]
C0571385
participant has poorly controlled diabetes mellitus, or requires insulin for glucose control.
Beskrivning

Poorly controlled diabetes mellitus | Insulin administration required for glucose control

Datatyp

boolean

Alias
UMLS CUI [1]
C0554876
UMLS CUI [2]
C4227726
participant is unable to swallow capsules and/or absorb oral medications
Beskrivning

Lacking Able to swallow Capsules | Lacking Able to swallow Oral medication

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0332268
UMLS CUI [1,2]
C2712086
UMLS CUI [1,3]
C0006935
UMLS CUI [2,1]
C0332268
UMLS CUI [2,2]
C2712086
UMLS CUI [2,3]
C0175795
participant is pregnant or breastfeeding, or expecting to conceive children within the projected duration of the study.
Beskrivning

Pregnancy | Breast Feeding | Pregnancy, Planned

Datatyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0032992
participant is known to be human immunodeficiency virus (hiv)-positive
Beskrivning

HIV Seropositivity

Datatyp

boolean

Alias
UMLS CUI [1]
C0019699
participant has known history of active hepatitis b or c.
Beskrivning

Hepatitis B | Hepatitis C

Datatyp

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2]
C0019196
participant is concurrently using growth hormone (gh) or growth hormone inhibitors
Beskrivning

Growth Hormone | Growth Hormone Receptor Antagonist

Datatyp

boolean

Alias
UMLS CUI [1]
C0037663
UMLS CUI [2]
C1947982
participant has significant or uncontrolled cardiovascular disease, including heart failure, unstable angina, or a myocardial infarction within the last 6 months
Beskrivning

Cardiovascular Disease | Cardiovascular Disease Uncontrolled | Heart failure | Angina, Unstable | Myocardial Infarction

Datatyp

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2,1]
C0007222
UMLS CUI [2,2]
C0205318
UMLS CUI [3]
C0018801
UMLS CUI [4]
C0002965
UMLS CUI [5]
C0027051
Tillbaka till toppen

Similar models

Eligibility Breast Cancer NCT01220570

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Invasive carcinoma of breast Operable TNM Breast tumor staging | Tumor Estrogen receptor positive | Tumor HER2 Negative | Tumor Histologic Grade | Tumor Ki67 Measurement
Item
participant has operable stage i-iiia invasive breast cancer of the following subtype: er-positive, her2-negative tumor with histologic grade 2 or 3 and ki67 ≥ 15%
boolean
C0853879 (UMLS CUI [1,1])
C0205188 (UMLS CUI [1,2])
C0474926 (UMLS CUI [1,3])
C0027651 (UMLS CUI [2,1])
C0279754 (UMLS CUI [2,2])
C0027651 (UMLS CUI [3,1])
C2348908 (UMLS CUI [3,2])
C0027651 (UMLS CUI [4,1])
C0919553 (UMLS CUI [4,2])
C0027651 (UMLS CUI [5,1])
C4049944 (UMLS CUI [5,2])
Tumor Diameter Physical Examination | Tumor Diameter Diagnostic radiologic examination
Item
tumor is at least 2 cm in diameter as assessed by physical or radiographic exam
boolean
C0027651 (UMLS CUI [1,1])
C1301886 (UMLS CUI [1,2])
C0031809 (UMLS CUI [1,3])
C0027651 (UMLS CUI [2,1])
C1301886 (UMLS CUI [2,2])
C0043299 (UMLS CUI [2,3])
Availability of Tissue specimen | Core needle biopsy | Status pre- Administration of medication
Item
participant consents to provide an existing tissue sample or to have a core needle biopsy before drug administration
boolean
C0470187 (UMLS CUI [1,1])
C1292533 (UMLS CUI [1,2])
C1318309 (UMLS CUI [2])
C0332152 (UMLS CUI [3,1])
C3469597 (UMLS CUI [3,2])
Availability of Tissue specimen | Status post Administration of medication | Core needle biopsy second | Surgical specimen
Item
participant consents to provide tissue samples following drug administration by a second core needle biopsy or from a surgical specimen
boolean
C0470187 (UMLS CUI [1,1])
C1292533 (UMLS CUI [1,2])
C0231290 (UMLS CUI [2,1])
C3469597 (UMLS CUI [2,2])
C1318309 (UMLS CUI [3,1])
C0205436 (UMLS CUI [3,2])
C1647891 (UMLS CUI [4])
Organ function
Item
participant must have adequate organ function
boolean
C0678852 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prior Chemotherapy Breast Carcinoma | Biological treatment Breast Carcinoma | Prior radiation therapy Breast Carcinoma
Item
participant has received any prior chemotherapy, biological therapy or radiotherapy for breast cancer
boolean
C1514457 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C1531518 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
C0279134 (UMLS CUI [3,1])
C0678222 (UMLS CUI [3,2])
Hypersensitivity Investigational New Drugs Component | Hypersensitivity Investigational New Drugs Analogs | Allergy to macrolide antibiotic | Clarithromycin allergy | Allergy to erythromycin | Azithromycin allergy
Item
participant has a known hypersensitivity to the components of study drugs or their analogs, including hypersensitivity to macrolide antibiotics (e.g. clarithromycin, erythromycin, azithromycin).
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C1705248 (UMLS CUI [1,3])
C0020517 (UMLS CUI [2,1])
C0013230 (UMLS CUI [2,2])
C0243071 (UMLS CUI [2,3])
C0571383 (UMLS CUI [3])
C0571384 (UMLS CUI [4])
C0014808 (UMLS CUI [5])
C0571385 (UMLS CUI [6])
Poorly controlled diabetes mellitus | Insulin administration required for glucose control
Item
participant has poorly controlled diabetes mellitus, or requires insulin for glucose control.
boolean
C0554876 (UMLS CUI [1])
C4227726 (UMLS CUI [2])
Lacking Able to swallow Capsules | Lacking Able to swallow Oral medication
Item
participant is unable to swallow capsules and/or absorb oral medications
boolean
C0332268 (UMLS CUI [1,1])
C2712086 (UMLS CUI [1,2])
C0006935 (UMLS CUI [1,3])
C0332268 (UMLS CUI [2,1])
C2712086 (UMLS CUI [2,2])
C0175795 (UMLS CUI [2,3])
Pregnancy | Breast Feeding | Pregnancy, Planned
Item
participant is pregnant or breastfeeding, or expecting to conceive children within the projected duration of the study.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
HIV Seropositivity
Item
participant is known to be human immunodeficiency virus (hiv)-positive
boolean
C0019699 (UMLS CUI [1])
Hepatitis B | Hepatitis C
Item
participant has known history of active hepatitis b or c.
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
Growth Hormone | Growth Hormone Receptor Antagonist
Item
participant is concurrently using growth hormone (gh) or growth hormone inhibitors
boolean
C0037663 (UMLS CUI [1])
C1947982 (UMLS CUI [2])
Cardiovascular Disease | Cardiovascular Disease Uncontrolled | Heart failure | Angina, Unstable | Myocardial Infarction
Item
participant has significant or uncontrolled cardiovascular disease, including heart failure, unstable angina, or a myocardial infarction within the last 6 months
boolean
C0007222 (UMLS CUI [1])
C0007222 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0018801 (UMLS CUI [3])
C0002965 (UMLS CUI [4])
C0027051 (UMLS CUI [5])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial